Start with the hormone, not the hype
GLP-1 — glucagon-like peptide-1 — is a hormone your gut releases after you eat. Its job is to tell your brain you're satisfied and to help your body manage blood sugar. It's part of the normal machinery you already run; nothing exotic about it.
GLP-1 medications like semaglutide and tirzepatide copy that signal. They're studied for quieting the constant food noise, helping you feel full sooner, and supporting steadier glucose. They're the medications behind the weight-care conversation you've been hearing — but how they're used matters as much as what they are.
What it's studied to do
In the research, GLP-1 receptor agonists act on the brain's hunger and fullness centers and slow how quickly the stomach empties, so people often describe feeling full sooner and longer. They also support glucose-dependent insulin release.
None of that is a promise about your results. Individual experience varies, and we describe how the medicine is studied to work — never a number you'll personally hit.
Why a provider sits in the middle
GLP-1 therapy is typically started low and titrated upward over time to balance results against side effects. That titration is a clinical decision, not a self-serve dial.
A US-licensed provider reviews your history, decides whether GLP-1 care is appropriate, sets every dose, and adjusts as your body responds. No provider review, no prescription. That gate is the point.
A note on this guide: This is general education, not medical advice or a promise about your results. Individual results vary, these therapies can cause side effects, and a US-licensed provider decides whether any treatment is appropriate for you. Compounded medications are not FDA-approved.
Mentioned in this guide
Explore the program